medigraphic.com

2008, Number S2

<< Back Next >>

Arch Cardiol Mex 2008; 78 (S2)

Hypertension in women

Lomelí C, Rosas M, Mendoza-González C, Lorenzo JA, Pastelín G, Méndez A, Mario FS, Attie F

Language: Spanish
References: 23
Page: 98-103
PDF size: 99.15 Kb.


ABSTRACT

The cardiovascular disease is a crucial cause of morbidity and mortality in the woman mainly when they arrive at menopause. The pathophysiology and neurohormonal mechanisms widely vary with respect to the man. This finding has given the support to think that the estrogens may be playing a protector role in cardiovascular disease. However, the associated risk factors like obesity, diabetes, dislipidemia, smoking and sedentary life are increasing in an exponential form. In Mexico the population age distribution establishes that 60% of the women with hypertension are aged ‹ 54 years old. This is reason why as factor of independent cardiovascular risk is commonest. Nevertheless, after the menopause cardiovascular mortality is greater in the woman than in the man. In this review, the importance of the new pathophysiological mechanisms and the clinical-therapeutic approach are analyzed, making emphasis in the importance of the change in the life style and also in the nutritional aspects. In Mexico the woman still have a unique role in the nutritional culture.


REFERENCES

  1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld I, Manolio T, Zheng ZJ, Flegal K, O’Donnell C, et al: American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113: e85-e151.

  2. Lloyd-Jones DM, Evans JC, Levy D: Hypertension in adults across the age spectrum. JAMA 2005; 294(4): 466-472.

  3. Velázquez-Monroy O, Rosas PM, Lara EA, Pastelín HG. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: Resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Méx 2003; 73: 62-77.

  4. William BK, Hjortland MC, McNamara PM, Gordon T: Menopause and risk of cardiovascular disease. Annals of Internal Medicine 1976; 85: 447-452.

  5. Chapman AB, Zamudio S, Woodmansee W: Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 1997; 273: 777-782.

  6. Dunne FP, Barry DG, Freís JB, Grealy G, Murphy D: Changes in blood pressure during the normal menstrual cycle. Clin Sci Oct 1991; 81: 515-518.

  7. Karpanou EA, Vyssoulis GP, Georgoudi DG, Toutouza MG, Toutouzas PK: Ambulatory blood pressure changes in the menstrual cycle of hypertensive women. Significance of plasma renin activity values. Am J Hypertens 1993; 6: 654-659.

  8. August P, Lenz T, Ales KL, et al: Longitudinal study of the renin angiotensin system in hypertensive women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990; 163: 1612-1621.

  9. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. The New England Journal of Medicine 1999; 340: 1801-1807.

  10. Cnop M, Landchild MJ, Vidal J: The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistence and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002; 51: 1005-1015.

  11. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA: Abdominal adiposity and coronary heart disease in women. JAMA1998; 280: 1843-1848.

  12. Tchernof A, Desmeules A, Richard C, Laberge P, Daris M, Mailloux J: Ovarian hormon status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab 2004; 89: 3425-3430.

  13. Nordby G, OsI, Kjeldsen SE, Eide I: Mild essential hypertension in nonobese premenopausal women is characterized by low renin. Am J. Hypertens 1992; 5: 579-584.

  14. Dubey RK, Oparil S, Imthurn B, Jackson EK: Sex hormones and hypertension. Cardiovasc Res 2002; 53: 688-708.

  15. Reckelhoff JF: Gender differences in the regulation of blood pressure. Hypertension 2001; 37: 1199-208.

  16. Nordby G, Kjeldsen SE, Eide I: Mild essential hypertension in nonobese premenopausal women is characterized by low renin. Am J Hypertens 1992; 5: 579-84.

  17. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.

  18. Sos TA, Pickering TG, Sniderman K: Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309: 274.

  19. Wassrtheil-Smoller S, Anderson G, Psaty BM, et al: Hypertension and its treatment in postmenopausal women: basaline data from the Women´s Health Initiative. Hypertension 2000; 36: 780-789.

  20. Staessen JA, Ginocchio G, Thijs L: Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997; 11: 507-514.

  21. Mosca L, Collins P, Herrington DM, et al: Hormone replacement therapy and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 499-503.

  22. Dahlöf B, Devereux RB, Kjeldsen SE: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003.

  23. The ALLHAT officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzime inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.




2020     |     www.medigraphic.com